Q4 2017 13F Holders as of 12/31/2017
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
72.1M
-
Number of holders
-
48
-
Total 13F shares, excl. options
-
7.82M
-
Shares change
-
+600K
-
Total reported value, excl. options
-
$77.2M
-
Value change
-
+$5.97M
-
Number of buys
-
28
-
Number of sells
-
-15
-
Price
-
$9.87
Significant Holders of Ovid Therapeutics Inc. - Common Stock, par value $0.001 per share (OVID) as of Q4 2017
53 filings reported holding OVID - Ovid Therapeutics Inc. - Common Stock, par value $0.001 per share as of Q4 2017.
Ovid Therapeutics Inc. - Common Stock, par value $0.001 per share (OVID) has 48 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 7.82M shares
of 72.1M outstanding shares and own 10.86% of the company stock.
Largest 10 shareholders include FMR LLC (1.47M shares), BlackRock Inc. (1.06M shares), PUTNAM INVESTMENTS LLC (673K shares), JENNISON ASSOCIATES LLC (578K shares), Tekla Capital Management LLC (536K shares), OppenheimerFunds, Inc. (425K shares), Vanguard Group Inc (334K shares), BAKER BROS. ADVISORS LP (333K shares), Redmile Group, LLC (313K shares), and PRICE T ROWE ASSOCIATES INC /MD/ (300K shares).
This table shows the top 48 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.